Feasibility Clinical Evaluation of the Calibreye System
ConditionGlaucoma, Open-Angle
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMyra Vision Inc.
About this trial
To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.
Eligibility criteria
Qualifiers
Open angle, pseudoexfoliative or pigmentary glaucoma
IOP at preoperative visit of ≥ 18mmHg and ≤ 45mmHg
Visual field mean deviation score of -3dB or worse
Area of healthy, free and mobile conjunctiva in the target quadrant
Disqualifiers
Angle closure glaucoma
Congenital, neovascular or other secondary glaucomas
Previous intraocular surgery (with the exception of laser trabeculoplasty or uncomplicated phacoemulsification with IOL occurring > 3 months prior to the preoperative visit)
Previous glaucoma shunt/valve in the target quadrant
Trial design
Treatments tested in this trial
- Calibreye System
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov